Repare Therapeutics
Biotechnology ResearchView the employees at
Repare Therapeutics-
Abira Rajah Research Scientist II, SNIPRx® Target Discovery Platform at Repare Therapeutics
-
Montreal, Quebec, Canada
-
Rising Star
Suzanne May Senior Operations Manager, Clinical Pharmacology and Toxicology at Repare Therapeutics-
Canada
-
Rising Star
Marie-Eve Leclaire Research Scientist III chez Repare Therapeutics-
St-Jean-Sur-Richelieu, Quebec, Canada
-
Rising Star
Frank V. Ingiosi, J.D., LL.M. Associate Director, Contracts Management with Repare Therapeutics-
Greater Philadelphia
-
Rising Star
Elia Aguado Fraile Senior Scientist II, Translational Science at Repare Therapeutics-
United States
-
Rising Star
Overview
Repare Therapeutics (Nasdaq: RPTX) is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs. For more information, please visit www.reparerx.com.
-